Kamada LtdNASDAQ:KMDA
- LAST PRICE5.1000
- TODAY'S CHANGE (%)0.0200 (0.3937%)
- Bid / Lots5.0000/ 10
- Ask / Lots7.1200/ 1
- Open / Previous Close5.1200 / 5.0800
- Day Range
- 52 Week Range
- Volume6,510
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KMDA |
|---|---|---|
| 09:32 ET | 301 | 5.12 |
| 09:38 ET | 100 | 5.09 |
| 11:13 ET | 349 | 5.08 |
| 11:38 ET | 200 | 5.06 |
| 03:20 ET | 100 | 5.02 |
| 03:50 ET | 100 | 5.07 |
| 03:57 ET | 3581 | 5.1 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kamada Ltd | 292.0M | 29.0x | -22.48% |
Sutro Biopharma Inc | 286.9M | -2.1x | --- |
Karyopharm Therapeutics Inc | 160.7M | -1.0x | --- |
Avid Bioservices Inc | 424.3M | -35.9x | --- |
Travere Therapeutics Inc | 455.9M | -1.2x | --- |
Entrada Therapeutics Inc | 410.6M | -46.8x | --- |
Company Information
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Contact Information
- Headquarters
- 2 Holtzman St., Science ParkREHOVOT, Israel 7670402
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Lilach Asher Topilsky
- Chief Executive Officer
- Amir London
- Deputy Chairman of the Board
- David Tsur
- Chief Financial Officer
- Chaime Orlev
- Senior Vice President - Scientific Affairs
- Ruth Wolfson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $292.0M |
|---|---|
Revenue (TTM) | $142.5M |
Shares Outstanding | 57.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.06 |
EPS | $0.18 |
Book Value | $4.25 |
P/E Ratio | 29.0x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | 13.9x |
Operating Margin | 7.06% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
